Our Mission
is to improve the lives of patients with serious diseases by pioneering therapies created with our revolutionary PROTAC® protein degradation platform.
We are Arvinas, a clinical-stage biotechnology company leading the way in the development of targeted protein degradation therapeutics.
We are singularly focused on developing an entirely new class of medicines that aims to be transformative for patients and their health care providers, turning targeted protein degradation into one of the promising areas of medical research and challenging the perceived limits of drug discovery.
If you’re inspired, please take a look at the current list of opportunities to join our team.
Our Hope is to Revolutionize Drug Discovery
Our team is driving some of the significant breakthroughs in the industry and enabling an expansive pipeline of targets in oncology and neuroscience.
Together, we are bringing novel investigational research to patients who need it most. With multiple products in development, we are exploring how PROTAC® protein degraders bridge our preclinical platform into the clinic.
Learn more about our therapeutic programs.
ABOUT ARVINAS
Leading the Way with Innovation
Every day at Arvinas, we work to advance pioneering science to develop new, transformative treatments for patients with limited treatment options, or for whom existing treatments have not been effective.
Partnerships are a Pivotal Part of Our ProcessWe partner with leading drug companies, academic experts, and innovative partners to further broaden and accelerate our clinical programs.Partnerships are a Pivotal Part of Our Process
